Lagos: The National Agency for Food and Drug Administration and Control (NAFDAC) has debunked a video circulating on social media alleging that the agency secretly banned the sale and use of Amoxicillin in the country. The Director-General of NAFDAC, Prof. Mojisola Adeyeye, stated that the claim was false and devoid of any factual basis regarding the banning of Amoxicillin, either secretly or openly.
According to News Agency of Nigeria, Prof. Adeyeye emphasized that as a responsible regulatory authority, NAFDAC publicly notifies Nigerians of any regulatory actions through official channels. The agency uses Recalls, Safety Alerts, Blacklists, and other safety notices to alert the public about any substandard, falsified, or affected products that require regulatory action. These safety communications clearly outline the specific product names, batch numbers, manufacturers, and the necessary measures to be taken. They provide critical information that may impact treatment and diagnostic decisions for healthcare providers and patients. Blacklisting, where applicable, involves prohibiting specific companies from the sale, distribution, or use of their products due to safety concerns, regulatory violations, or unethical practices.
Prof. Adeyeye further explained that in recent months, NAFDAC issued targeted safety alerts on certain brands and batches of Amoxicillin. In August 2025, Public Alert No. 24/2025 announced the recall of Amoxivue (Amoxicillin) 500mg capsules due to low Active Pharmaceutical Ingredient (API) content. The agency also issued a public alert in October 2025 on substandard batches of Astamocil and Astamentin suspensions, and Public Alert No. 35/2025 notified the public of substandard batches of Annmox and Jawamox suspensions.
These actions, she clarified, are specific to identified products and do not constitute a ban on Amoxicillin. Prof. Adeyeye advised members of the public to disregard the misleading video.